Seeking Alpha
  • Michael Bryant
    "GlaxoSmithKline (GSK) is nearing a deal to acquire Human Genome Sciences (GSK) for about $2.8 billion in cash." HGSI market cap is $2.7B.
    7/16/12
    Reply (1)
    • Michael Bryant: http://yhoo.it/Nvk4pw
      7/16/12